Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2031³â)
Target Humanized Mice Market Report: Trends, Forecast and Competitive Analysis to 2031
»óǰÄÚµå : 1818247
¸®¼­Ä¡»ç : Lucintel
¹ßÇàÀÏ : 2025³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,850 £Ü 5,537,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,688,000
PDF (2 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,350 £Ü 7,694,000
PDF (5 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,050 £Ü 10,140,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ ±â¾÷ ³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀåÀÇ ¹Ì·¡´Â ¾Ï ¿¬±¸, ¸é¿ªÄ¡·á, ¾à¹° ½ºÅ©¸®´× ½ÃÀå¿¡¼­ ±âȸ°¡ ÀÖÀ¸¸ç, À¯¸ÁÇÑ ½ÃÀåÀ¸·Î Æò°¡¹Þ°í ÀÖ½À´Ï´Ù. ¼¼°è Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀåÀº 2025³âºÎÅÍ 2031³â±îÁö 8.9%ÀÇ ¿¬Æò±Õ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¸ÂÃãÇü Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í À¯ÀüÀÚ ÆíÁý ±â¼úÀÇ ¹ßÀüÀÔ´Ï´Ù.

Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ

À¯Àü°øÇÐÀÇ ¹ßÀü, Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, º¸´Ù Á¤È®ÇÑ ÀüÀÓ»ó ¸ðµ¨¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀ» ¹è°æÀ¸·Î Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀåÀº ºü¸£°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â »ý¹°ÀÇÇÐ ¿¬±¸ ºÐ¾ß¸¦ À籸¼ºÇϰí, ÀǾàǰ °³¹ß, ¸ÂÃãÇü ÀÇ·á, Áúº´ ÀÌÇØ¸¦ À§ÇÑ »õ·Î¿î ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ´ÙÀ½Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â 5°¡Áö ÁÖ¿ä Æ®·»µåÀÔ´Ï´Ù.

ÀÌ·¯ÇÑ »õ·Î¿î Ãß¼¼´Â À¯Àü°øÇÐÀÇ Çõ½Å, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡, »ý¸í°øÇп¡ ´ëÇÑ ÅõÀÚ Áõ°¡ µî¿¡ ÈûÀÔ¾î Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀåÀÌ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Ù´Â °ÍÀ» º¸¿©ÁÝ´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â °è¼Ó ÁøÈ­Çϰí ÀÖÀ¸¸ç, »ý¹° ÀÇÇÐ ¿¬±¸ ¼öÇà ¹æ¹ýÀ» À籸¼ºÇÏ°í º¸´Ù Á¤È®Çϰí È¿À²ÀûÀÎ ÀüÀÓ»ó ¸ðµ¨ °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ

Ãֱ٠ǥÀû Àΰ£È­ ¸¶¿ì½º ½ÃÀåÀÇ µ¿ÇâÀº À¯Àü°øÇÐÀÇ ºñ¾àÀûÀÎ ¹ßÀü, ½Å¾à°³¹ß¿¡ ´ëÇÑ »õ·Î¿î ÀÀ¿ë, ¿¬±¸ÀÚ±ÝÀÇ Áõ°¡ µî Å« º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³¹ß·Î ÀÎÇØ Àΰ£È­ ¸¶¿ì½º´Â Á¤¹ÐÀÇ·á, Áúº´ ¸ðµ¨¸µ, ¾à¹° ½ÃÇè¿¡¼­ Áß¿äÇÑ µµ±¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ´ÙÀ½Àº ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ´Â 5°¡Áö ÁÖ¿ä ¹ßÀüÀÔ´Ï´Ù.

Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀåÀÇ ÁÖ¿ä ¹ßÀüÀº »ý¹° ÀÇÇÐ ¿¬±¸ ¹ßÀü¿¡¼­ ÀÌ·¯ÇÑ ¸ðµ¨ÀÇ Á߿伺ÀÌ Áõ°¡Çϰí ÀÖÀ½À» µÞ¹ÞħÇÕ´Ï´Ù. À¯ÀüÀÚ ÆíÁýÀÇ Çõ½Å, ¸é¿ªÁ¾¾çÇÐ ¿¬±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, »êÇÐÇù·ÂÀº º¸´Ù Á¤È®ÇÏ°í ºñ¿ë È¿À²ÀûÀÌ¸ç Æ¯¼öÇÑ Àΰ£È­ ¸¶¿ì½º ¸ðµ¨ °³¹ß·Î À̾îÁ® ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

Á¦4Àå À¯Çüº° ¼¼°èÀÇ Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀå

Á¦5Àå ¿ëµµº° ¼¼°èÀÇ Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀå

Á¦6Àå Áö¿ª ºÐ¼®

Á¦7Àå ºÏ¹ÌÀÇ Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀå

Á¦8Àå À¯·´ÀÇ Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀå

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀå

Á¦10Àå ±âŸ Áö¿ªÀÇ Ç¥Àû Àΰ£È­ ¸¶¿ì½º ½ÃÀå

Á¦11Àå °æÀï ºÐ¼®

Á¦12Àå ±âȸ¿Í Àü·« ºÐ¼®

Á¦13Àå ¹ë·ùüÀÎ Àüü¿¡ °ÉÄ£ ÁÖ¿ä ±â¾÷ °³¿ä

Á¦14Àå ºÎ·Ï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The future of the global target humanized mice market looks promising with opportunities in the cancer research, immunity therapy, and drug screening markets. The global target humanized mice market is expected to grow with a CAGR of 8.9% from 2025 to 2031. The major drivers for this market are the increasing demand for personalized treatment and the rising advancement in gene editing technologies.

Emerging Trends in the Target Humanized Mice Market

The target humanized mice market is evolving rapidly, driven by advancements in genetic engineering, increased demand for precision medicine, and the growing need for more accurate preclinical models. These trends are reshaping the field of biomedical research, offering new opportunities for drug development, personalized medicine, and disease understanding. Below are five key trends that are influencing the market.

These emerging trends highlight the rapid growth of the target humanized mice market, fueled by innovations in genetic engineering, a growing emphasis on personalized medicine, and increased investments in biotechnology. As these trends continue to evolve, they are reshaping how biomedical research is conducted and driving the development of more accurate and efficient preclinical models.

Recent Developments in the Target Humanized Mice Market

Recent developments in the target humanized mice market have been transformative, with breakthroughs in genetic engineering, new applications in drug discovery, and increased research funding. These developments are positioning humanized mice as critical tools in precision medicine, disease modeling, and drug testing. Below are five key developments that are shaping the market.

The key developments in the target humanized mice market underscore the growing importance of these models in advancing biomedical research. Innovations in genetic editing, increased demand for immuno-oncology research, and partnerships between industry and academia are driving the market forward, leading to the development of more accurate, cost-effective, and specialized humanized mice models.

Strategic Growth Opportunities in the Target Humanized Mice Market

The target humanized mice market offers several growth opportunities across a variety of applications, driven by advancements in genetic engineering and the increasing need for precision models in drug testing and disease research. Below are five key growth opportunities by application that are shaping the future of the market.

The strategic growth opportunities in the target humanized mice market are diverse, spanning cancer research, personalized medicine, regenerative therapies, infectious diseases, and safety testing. These applications are driving innovation in the market, with humanized mice models playing a critical role in advancing drug discovery and biomedical research.

Target Humanized Mice Market Driver and Challenges

The target humanized mice market is influenced by a range of technological, economic, and regulatory factors. Advances in biotechnology and genetic engineering have driven the development of humanized mouse models, which are essential for drug discovery and immunology research. Economic trends, such as increasing investment in life sciences and healthcare, further stimulate market growth. At the same time, regulatory factors, including ethical guidelines and animal welfare regulations, present challenges. Understanding the key drivers and challenges impacting this market is crucial for stakeholders to navigate the evolving landscape and harness the potential of humanized mice in biomedical research.

The factors responsible for driving the target humanized mice market include:

1. Advances in Biotechnology and Genetic Engineering: Technological advancements in biotechnology and genetic engineering are a major driver for the target humanized mice market. The development of more precise gene-editing technologies, such as CRISPR, has significantly improved the creation of humanized mouse models. These models are increasingly able to mimic human diseases more accurately, enhancing their utility in drug discovery, immunotherapy, and cancer research. As research requires more advanced and reliable animal models, the demand for humanized mice continues to rise, driving market growth and innovation in genetic engineering techniques.

2. Growing Pharmaceutical and Biotechnology Investments: The increasing investment in the pharmaceutical and biotechnology industries plays a critical role in driving demand for Target Humanized Mice. As drug discovery and development become more complex, humanized mice models are crucial in testing the efficacy and safety of new treatments. These models provide more reliable results than traditional animal models, accelerating the development process and reducing the time and cost of clinical trials. With growing investments in personalized medicine and immunotherapies, the need for humanized mice continues to expand, fostering growth in the market.

3. Demand for More Accurate Preclinical Models: There is a growing demand for more accurate and reliable preclinical models to improve the predictability of drug responses in humans. Traditional animal models often fail to replicate human physiology and disease mechanisms effectively, leading to high failure rates in clinical trials. Humanized mice, however, are better equipped to simulate human immune systems and disease conditions, providing more accurate data in preclinical testing. As a result, researchers and pharmaceutical companies are increasingly turning to humanized mice, driving market growth and the demand for innovative, high-quality models.

4. Increasing Focus on Immunotherapy and Personalized Medicine: The growing focus on immunotherapy and personalized medicine has significantly impacted the target humanized mice market. Humanized mice are invaluable in studying immune responses, cancer therapies, and the development of personalized treatment regimens. These models allow researchers to test therapies that are tailored to individual genetic profiles, improving treatment outcomes. With the rise of immuno-oncology and other targeted therapies, the demand for humanized mouse models to evaluate new treatments is expected to continue expanding, further driving market growth in the coming years.

5. Expansion of Healthcare Research and Clinical Trials: The expansion of healthcare research and clinical trials has led to a higher demand for humanized mice in preclinical testing. As healthcare research accelerates globally, there is an increasing need for reliable animal models that can mimic human disease and treatment responses accurately. Humanized mice provide the necessary tools for testing a wide range of therapeutic strategies, especially in oncology, immunology, and infectious diseases. The increasing number of clinical trials and research projects globally ensures the sustained growth of the humanized mice market as researchers continue to prioritize these models for their clinical relevance.

Challenges in the target humanized mice market are:

1. Ethical and Regulatory Concerns: Ethical and regulatory concerns surrounding the use of animals in research represent a significant challenge in the target humanized mice market. Stricter animal welfare regulations are being implemented globally, leading to greater scrutiny of the use of animal models in biomedical research. Researchers and companies must comply with ethical guidelines, such as the 3Rs (Replacement, Reduction, and Refinement), to minimize animal use and suffering. These regulations can increase the cost and complexity of developing and maintaining humanized mice models, as well as create potential delays in research timelines.

2. High Cost of Development and Maintenance: The development and maintenance of humanized mice models are expensive and resource-intensive. Producing humanized mice requires advanced genetic engineering techniques, specialized facilities, and highly skilled personnel, making them more costly than traditional animal models. Additionally, maintaining the health and genetic integrity of these mice over time requires significant investment in breeding, care, and monitoring. The high cost of development and maintenance may limit access to these models for smaller research institutions and companies, hindering widespread adoption and slowing market growth in some regions.

3. Limited Availability of Suitable Models: Another key challenge is the limited availability of suitable humanized mouse models for specific research needs. While significant progress has been made, the process of humanizing mice to accurately represent human diseases is still complex and resource-heavy. Researchers may find it difficult to access models that match specific disease conditions or genetic variations, limiting their ability to perform targeted research. This shortage of suitable models can delay research progress and restrict the potential applications of humanized mice, impacting market growth and the development of innovative therapies.

The target humanized mice market is driven by technological advancements in biotechnology, increasing investments in pharmaceutical and biotech industries, and a growing need for more accurate preclinical models. The expansion of immunotherapy and personalized medicine further fuels demand, alongside the increasing focus on healthcare research and clinical trials. However, challenges such as ethical and regulatory concerns, high development costs, and limited availability of specific models present hurdles to market growth. Navigating these challenges while leveraging the drivers will be essential for stakeholders to maximize the potential of humanized mice in advancing biomedical research and drug development.

List of Target Humanized Mice Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies target humanized mice companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the target humanized mice companies profiled in this report include-

Target Humanized Mice Market by Segment

The study includes a forecast for the global target humanized mice market by type, application, and region.

Target Humanized Mice Market by Type [Value from 2019 to 2031]:

Target Humanized Mice Market by Application [Value from 2019 to 2031]:

Target Humanized Mice Market by Region [Value from 2019 to 2031]:

Country Wise Outlook for the Target Humanized Mice Market

The target humanized mice market is influenced by a range of technological, economic, and regulatory factors. Advances in biotechnology and genetic engineering have driven the development of humanized mouse models, which are essential for drug discovery and immunology research. Economic trends, such as increasing investment in life sciences and healthcare, further stimulate market growth. At the same time, regulatory factors, including ethical guidelines and animal welfare regulations, present challenges. Understanding the key drivers and challenges impacting this market is crucial for stakeholders to navigate the evolving landscape and harness the potential of humanized mice in biomedical research.

Features of the Global Target Humanized Mice Market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Trends & Forecast Analysis

4. Global Target Humanized Mice Market by Type

5. Global Target Humanized Mice Market by Application

6. Regional Analysis

7. North American Target Humanized Mice Market

8. European Target Humanized Mice Market

9. APAC Target Humanized Mice Market

10. ROW Target Humanized Mice Market

11. Competitor Analysis

12. Opportunities & Strategic Analysis

13. Company Profiles of the Leading Players Across the Value Chain

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â